# Protagonist Therapeutics funding: rounds and investors > Protagonist Therapeutics has raised $89M across 5 rounds since 2006. Investors include Starfish Ventures, Lilly Ventures and Canaan. Source: https://millionrounds.com/company/protagonist-therapeutics (Millionrounds; every figure on the page links to its filing or article) Australia · [Funded startup](https://millionrounds.com/companies) # Who invested in *Protagonist Therapeutics* 5 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$89M** raised across 5 rounds since 2006, from 5 sources **$9.0M** Series A **$14M** Series B **$4.0M** Series B **$40M** Series C **$22M** Round - **Latest round:** Round, $22M Aug 2018 - **Biggest round:** $40M Series C · Jul 2015 - **Investors:** 10 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2006 2008 2010 2012 2014 2016 2018 **$9.0M** Series A **$14M** Series B **$4.0M** Series B **$40M** Series C **$22M** Round - **First round:** Series A, $9.0M - **Biggest round:** $40M - **Usual gap between rounds:** 3.1 years ## The rounds - **Aug 2018** Round **$22M** *1 new* [BVF Partners](https://millionrounds.com/fund/bvf-partners) Reported by FinSMEs - **Jul 2015** Series C **$40M** *4 new* [Canaan](https://millionrounds.com/fund/canaan-partners) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) From a historical funding record SEC filing: $17M sold, first sale Jul 2015 - **Sept 2013** Series B **$4.0M** *1 new* [Pharmstandard](https://millionrounds.com/fund/pharmstandard) Reported by pevc.dowjones.com SEC filing: $7.0M sold, first sale May 2013 - **Jun 2013** Series B **$14M** *1 new* *2 returning* [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) [Starfish Ventures](https://millionrounds.com/fund/starfish-ventures) [Lilly Ventures](https://millionrounds.com/fund/lilly-ventures) Reported by protagonist-inc.com SEC filing: $7.0M sold, first sale May 2013 - **Sept 2006** Series A **$9.0M** *3 new* [Starfish Ventures](https://millionrounds.com/fund/starfish-ventures) [Lilly Ventures](https://millionrounds.com/fund/lilly-ventures) [QIC BioVentures](https://millionrounds.com/fund/qic-bioventures) Reported by protagonist-inc.com ## Founders and team From the SEC filings it signed: 1 on the team. - **Dinesh V. Patel** Executive Officer, Director i On the board, as filed i *Armen V. Shanafelt* *Asish K. Xavier* *Harold E. Selick* *Michael K. Panaccio* *Paul F. Truex* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2006 **Series B** 2013 **Series B** 2013 **Series C** 2015 **Round** 2018 [Starfish Ventures](https://millionrounds.com/fund/starfish-ventures) [Lilly Ventures](https://millionrounds.com/fund/lilly-ventures) [Canaan](https://millionrounds.com/fund/canaan-partners) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) [BVF Partners](https://millionrounds.com/fund/bvf-partners) [Pharmstandard](https://millionrounds.com/fund/pharmstandard) [QIC BioVentures](https://millionrounds.com/fund/qic-bioventures) ## Everyone who backed them [Starfish Ventures](https://millionrounds.com/fund/starfish-ventures) VC firm **2** rounds [Lilly Ventures](https://millionrounds.com/fund/lilly-ventures) Corporate VC **2** rounds [Canaan](https://millionrounds.com/fund/canaan-partners) VC firm **1** round [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round [Foresite Capital](https://millionrounds.com/fund/forsite-capital) Private equity **1** round [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) VC firm **1** round [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) Asset manager **1** round [BVF Partners](https://millionrounds.com/fund/bvf-partners) VC firm **1** round [Pharmstandard](https://millionrounds.com/fund/pharmstandard) Corporate VC **1** round [QIC BioVentures](https://millionrounds.com/fund/qic-bioventures) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=protagonist-therapeutics). ## Also claim to have backed them This firm lists Protagonist Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Aisling Capital](https://millionrounds.com/fund/aisling-capital) Private equity Per its own site ## Quick answers about Protagonist Therapeutics ### Who invested in Protagonist Therapeutics? Protagonist Therapeutics's investors include Starfish Ventures, Lilly Ventures, Canaan, RA Capital Management and Foresite Capital, and 5 more on record. ### How much has Protagonist Therapeutics raised? Protagonist Therapeutics has raised $89M across 5 rounds since 2006. ### When did Protagonist Therapeutics last raise? Protagonist Therapeutics's most recent round was an Undisclosed round of $22M in Aug 2018. ### What was Protagonist Therapeutics's biggest round? Protagonist Therapeutics's largest round on record is $40M (Series C), in Jul 2015. ### Who backed Protagonist Therapeutics first? Protagonist Therapeutics's first round on record, in Sept 2006, was backed by Starfish Ventures, Lilly Ventures and QIC BioVentures. ### What stage is Protagonist Therapeutics at? Protagonist Therapeutics's latest named round is an Undisclosed round, in Aug 2018. ### Where is Protagonist Therapeutics based? Protagonist Therapeutics is based in Australia. ## Companies like Protagonist Therapeutics In the same sector, and raised in the last eighteen months. [**Kinoxis Therapeutics** $14M · Sept 2026](https://millionrounds.com/company/kinoxis-therapeutics)[**GonGlobal** $1.2M · Sept 2026](https://millionrounds.com/company/gonglobal)[**ENA Respiratory** $24M · Sept 2026](https://millionrounds.com/company/ena-respiratory)[**Elita** $3.2M · Sept 2026](https://millionrounds.com/company/elita)[**Heidi Health** $332M · Sept 2026](https://millionrounds.com/company/heidi-health)[**updoc** $23M · Sept 2026](https://millionrounds.com/company/updoc) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app